Browse investments

Invest in Catalyst Pharmaceuticals, Inc. on Stash

Catalyst Pharmaceuticals, Inc., formerly Catalyst Pharmaceutical Partners, Inc.

To buy fractional shares

of Catalyst Pharmaceuticals, Inc. stock, you'll need to sign up for Stash and open a personal portfolio.

Disclaimer: Any investment you’ve selected here, which may be available to Stash customers on the Stash platform, is intended to be used for informational purposes only, should not be relied upon as the sole basis for making any investment decision, and is not intended to be a recommendation or advice by Stash that is based on your investment time horizon and/or risk tolerance. This information should not be relied upon by the reader as research or investment advice regarding any issuer or security in particular. Investors who become Stash customers are offered investment advice and recommendations through various digital features such as Diversification Score Analysis based on what they tell us about their time horizon and risk tolerance. Investing Involves Risk.

Ticker: CPRX

Catalyst Pharmaceuticals, Inc.

$12.18

-5.80%

(1W)

The historical performance data for individual securities quoted on this website represents past performance reported as an average annual return for a given time horizon. Historical performance over the last 5 years, for example, is simply what the average return per year (compound annual growth rate) was for the investment over the past 5 years.

Historical performance data are provided “as is” and solely for information purposes, is not advice or for trading purposes, does not reflect an investment strategy, may be subject to pricing delays, should not be used for tax reporting, may not reflect actual performance, and are gross of Stash fees. Market data provided by Thomson Reuters (Refinitiv). ©2023 Thomson Reuters. Stash cannot and does not represent or guarantee that any of the information available via Refinitiv is accurate, reliable, current, complete or appropriate for your needs. This material does not contain sufficient information to support an investment decision and it should not be relied upon by you in evaluating the merits of investing in any securities or products. In addition, users should make an independent assessment of the legal, regulatory, tax, credit and accounting implications and determine performance and yield are not a reliable indicator of current and future results.

CPRX Performance Breakdown

Share Price

$12.18

Today's change

0.0%

Year to date change (YTD)

-32.56%

Dividend yield

N/A

Last dividend paid

N/A

Last dividend pay date

N/A

About CPRX

Catalyst Pharmaceuticals, Inc., formerly Catalyst Pharmaceutical Partners, Inc., is a development-stage biopharmaceutical company. The Company is focused on developing and commercializing therapies for people with rare debilitating diseases. The Company has three drugs in development: Firdapse, CPP-109 and CPP-115. The Company's Firdapse is indicated for the treatments of lambert-eaton myasthenic syndrome (LEMS) and congenital myasthenic syndromes (CMS). Firdapse consists of the phosphate salt of amifampridine. The Company has completed the Phase III trial of Firdapse. The Company's CPP-109 (vigabatrin) is a gamma-aminobutyric acid (GABA) aminotransferase inhibitor. CPP-109 is indicated for the treatment of Tourette's Disorder. The Company's CPP-115 is a GABA aminotransferase inhibitor. CPP-115 is indicated for the treatment of selected neurological indications, such as complex partial seizures and Tourette's Disorder, and epilepsy.

Catalyst Pharmaceuticals, Inc. Stock Ticker

CPRX

For more information

https://www.catalystpharma.com

Invest in Catalyst Pharmaceuticals, Inc. on Stash

Catalyst Pharmaceuticals, Inc., formerly Catalyst Pharmaceutical Partners, Inc.

To buy fractional shares

of Catalyst Pharmaceuticals, Inc. stock, you'll need to sign up for Stash and open a personal portfolio.

Certain companies are volatile.

Certain companies can be volatile, meaning the stock price fluctuates significantly. Don’t put all your eggs into one basket and remember to keep the Stash Way in mind when you invest.

Catalyst Pharmaceuticals, Inc. stock news

This site provides links to other third-party internet sites, which are identified, indexed and compiled through an automated process with no advance review by Stash. By directing users to the below third-party websites, Stash is not suggesting any endorsement, relationship, affiliation with any such websites.

CNBC

Illumina shareholders vote to install Carl Icahn board nominee, oust chair

Carl Icahn has accused Illumina's management and board of poor oversight, particularly with regard to the company's acquisition of cancer test maker Grail.

4 months ago

Business Insider

Dollar Tree is considering locking up products to deter theft

Dollar Tree faced higher "shrink" during the company's first quarter, executives said Thursday. "Shrink" is an industry term for products that have to be written off, including for theft.

4 months ago

24/7 Wall Street

4 Tech Companies Riding Nvidia's Wave

The top investing story of the day is Nvidia Corp.'s (NASDAQ: NVDA) solid first-quarter results, accompanied by a hard-to-believe second-quarter revenue outlook that was 50% higher than the Wall Street estimate.

4 months ago

See It Market

Disney Stock (DIS) Seeking Shelter From The Storm

It's been a rough couple of years for Disney and its stock price. A mix of political headlines and lackluster earnings hit the company hard last year.

4 months ago

Why invest with Stash?

Fractional shares

Thousands of stocks and ETFs. No investing minimums.

Unlimited trades

Plus no add-on trading commission fees.^†

Diversification analysis

Custom investment recommendations can help you diversify.

Automatic investing

Dividend reinvestment,⁸ recurring investments, and more.

The Stock-Back® Card

We’ll give you matching stock in companies you shop at.¹

Learn how to invest

Get professional advice and education at every step.

How to buy Catalyst Pharmaceuticals, Inc. stock on Stash

Stash allows you to purchase smaller, more affordable pieces of investments (called fractional shares) rather than the whole share, which can be significantly more expensive.

Catalyst Pharmaceuticals, Inc.’s share price is determined by its bid-ask spread, which is the difference between the price that buyers are willing to pay and the price that sellers are willing to accept. Catalyst Pharmaceuticals, Inc.’s price can fluctuate throughout the course of each trading day—when you buy Catalyst Pharmaceuticals, Inc. through Stash, we execute the market order during our next available trading window (we have two a day). At Stash, we don’t recommend trying to predict the market when buying investments. We believe it can be a better strategy to buy quality investments you believe in, then hang onto them.

Use our historic performance chart to see real-time Catalyst Pharmaceuticals, Inc. stock price and the Catalyst Pharmaceuticals, Inc. news feed to help further your research before investing in fractional shares with any dollar amount you choose.

Stash offers two subscription plans: Stash Growth and Stash+.

Each plan can help you reach different goals and offers a unique combination of financial accounts and features. All plans include access to a personal brokerage account—also known as your personal investment account. You can use your Stash personal portfolio to purchase any of the available investments on our platform, as well as access our suite of automatic saving and investing tools. Learn more about Stash pricing.

Once your market order of Catalyst Pharmaceuticals, Inc. stock is complete, you'll officially be a shareholder of Catalyst Pharmaceuticals, Inc.!